ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GDR Genedrive Plc

5.375
-0.25 (-4.44%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -4.44% 5.375 5.25 5.50 5.625 5.375 5.625 1,268,205 14:37:32
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0447 -1.20 6.18M

Genedrive PLC Director/PDMR Shareholding (7445Y)

07/12/2017 4:28pm

UK Regulatory


Genedrive (LSE:GDR)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Genedrive Charts.

TIDMGDR

RNS Number : 7445Y

Genedrive PLC

07 December 2017

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that it has granted share options ("Options") to certain of its directors and senior management to acquire a total of 156,087 ordinary shares of 1.5p each in the capital of the Company under the Company's newly adopted 2017 Share Option Scheme.

The Options have been granted with an exercise price equal to the close price on the day before grant and vest after a period of three years. The Options will vest after 3 years only if certain performance criteria are met. The Options are exercisable over the period of 10 years from the date of grant.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 
 1.   Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------------------------- 
 a.   Name                                       1. Gordon Powell 
                                                  2. Gino Miele 
                                                  3. Nancy Neilson 
---  ------------------------------  ----------------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------------------------- 
 a.   Position/status                            1. Commercial Director 
                                                  2. R&D Director 
                                                  3. Quality Assurance Director 
---  ------------------------------  ----------------------------------------------- 
 a.   Initial notification            Initial notification 
       /Amendment 
---  ------------------------------  ----------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------------------------- 
 a.   Name                            genedrive plc 
---  ------------------------------  ----------------------------------------------- 
 b.   LEI                             213800ZYODIRZ87Y4K14 
---  ------------------------------  ----------------------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------------------------- 
 a.   Description                     Options over ordinary shares of 
       of the                          1.5 pence each 
       Financial 
       instrument, 
       type 
       of instrument 
       Identification 
       code 
---  ------------------------------  ----------------------------------------------- 
 b.   Nature of                       Grant of options pursuant to and 
       the transaction                 in accordance with the terms of 
                                       the Company's Share Option Scheme 
                                       dated 29 November 2017. 
---  ------------------------------  ----------------------------------------------- 
 c.   Price(s)                          Price(s)                 Option   Volume(s) 
       and volume(s)                                            price(s) 
                                        --------------------  ----------  ---------- 
                                              Gordon Powell      36.0p        88,063 
                                        --------------------  ----------  ---------- 
                                              Gino Miele         36.0p        43,024 
                                        --------------------  ----------  ---------- 
                                              Nancy Neilson      36.0p        25,000 
                                        --------------------  ----------  ---------- 
---  ------------------------------  ----------------------------------------------- 
 d.        Aggregated 
            information                 N/A 
             *    Aggregated volume 
 
 
             *    Price 
---  ------------------------------  ----------------------------------------------- 
 e.   Date of the                     2017-12-07; UTC time 
       transaction 
---  ------------------------------  ----------------------------------------------- 
 f.   Place of                        Outside trading venue - shares 
       the transaction                 to be admitted to AIM market of 
                                       London Stock Exchange plc on exercise 
                                       of options 
---  ------------------------------  ----------------------------------------------- 
 

For further details please contact:

 
 genedrive plc                         +44 (0)161 989 0245 
 David Budd: CEO 
 Matthew Fowler: CFO 
 Peel Hunt LLP                         +44 (0)207 418 8900 
 James Steel 
 Oliver Jackson 
 Consilium Strategic Communications    +44 (0)203 709 5700 
 Chris Gardner 
 Matthew Neal 
 Laura Thornton 
 genedrive@consilium-comms.com 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEAKAXEAKXFFF

(END) Dow Jones Newswires

December 07, 2017 11:28 ET (16:28 GMT)

1 Year Genedrive Chart

1 Year Genedrive Chart

1 Month Genedrive Chart

1 Month Genedrive Chart

Your Recent History

Delayed Upgrade Clock